How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.


Victory Pharma, Inc. is looking to expand its presence in the pain and related therapeutics field

Organization name

Victory Pharma, Inc.


Formed in 2003, Victory Pharma, Inc. acquires, markets and develops prescription pharmaceutical products that treat pain and related conditions.

From its inception, Victory´s strategy has focused on acquiring and developing products to generate significant sales and build a strong financial base and commercial infrastructure. As the Company evolved, an intellectual property platform was acquired which is suitable for multiple pain therapy development programs.  These programs are now being advanced into clinical trials. Today, Victory has transformed into a high-growth pain specialty pharmaceutical firm.

Victory Pharma, Inc. is looking to expand its presence in the pain and related therapeutics field through product acquisitions and partnerships. Part of Victory's long-term growth strategy includes acquiring, developing, or co-marketing products that fall under their areas of expertise.

These products should meet the following criteria:

  • Present differentiated characteristics
  • Have a territory that extends at least through North America
  • Have protection through IP, regulatory status, manufacturing processes
  • Represent a significant commercial opportunity

Products already approved should meet these criteria:

  • Responsive to promotion
  • Provides synergy with our projected customer base
  • Have clear brand recognition
  • Come with a defined supply chain

Products being considered for development should meet these criteria:

  • Have a relatively low scientific risk profile (specific clinical data required)
  • Display manageable cash outlay for development
  • Have a remaining development timeline of 2.5 years or less
  • Have known endpoints for regulatory development

Primary therapeutic area(s)

  • Mental and behavioural disorders
  • Diseases of the nervous system
  • Musculoskeletal system and connective tissue

 They are looking for products in

  • Arthritis
  • Gout
  • Joint Inflammation
  • Migrain
  • Muscle Relaxer
  • Nausea
  • Pain
  • Sleep / Depression

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.


latest entries